Deals Of The Week: GSK’s Stealth Move To The Coasts

16 Dec 2013

• By Paul Bonanos, Jessica Merrill, Michael Goodman, and Wendy Diller

The British pharma opens new innovation centers in San Diego and Cambridge, Mass., to connect with those academic, business and venture investment communities. Also, Roche and Biogen Idec make moves in neurodegenerative disease, Retrophin makes two deals for different forms of the same drug, and GSK makes the latest alliance in the cancer immunology arena.

GlaxoSmithKline PLC is following some of its big pharma peers to key innovation hubs in the U.S. by opening satellite R&D centers in San Diego and Cambridge, Mass.

When Johnson & Johnson opened its innovation center in Boston earlier this year, the company made a big to-do...